MNOV Q4 2024 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena

MNOVMediciNova, Inc.

$69M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$5,177

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$263,993

Balance Sheet

Total Assets

$56M

Total Liabilities

$3M

Stockholders' Equity

$53M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$5,177	-$5,492	+5.7%
Operating Income	-$3M	-$2M	-27.9%
Net Income	-$3M	-$2M	-36.7%